Nvidia invests $50 million in Recursion to train AI models for drug discovery
Nvidia (NVDA.O) invested $50 million to speed up training of biotech firm Recursion’s (RXRX.O) artificial intelligence models for drug discovery, which the chip designer can then potentially license ...